| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 03/18/2009 | CN101385780A Medicine composition for preventing the birth defect and improving the memory |
| 03/18/2009 | CN101385779A Medicament composition for preventing the birth defect and improving the memory and intelligence |
| 03/18/2009 | CN101385771A Medicine composition for preventing the birth defect and improving the memory |
| 03/18/2009 | CN101385767A Watermelon seeds oil soft capsules and preparation method thereof |
| 03/18/2009 | CN101385764A Use of snow ganoderma lucidum total saponin in preparing analgesic medicine |
| 03/18/2009 | CN101385761A Medicine composition for preventing the birth defect and improving the memory |
| 03/18/2009 | CN101385760A Medicine composition for preventing the birth defect and improving the memory |
| 03/18/2009 | CN101385759A Medicine composition for preventing the birth defect and improving the memory |
| 03/18/2009 | CN101385758A Medicine composition for preventing the birth defect and improving the memory |
| 03/18/2009 | CN101385757A Medicine composition for preventing the birth defect and improving the memory |
| 03/18/2009 | CN101385756A Medicine composition for preventing the birth defect and improving the memory |
| 03/18/2009 | CN101385755A Medicine composition for preventing the birth defect and improving the memory |
| 03/18/2009 | CN101385754A Medicine composition for preventing the birth defect and improving the memory |
| 03/18/2009 | CN101385753A Medicine composition for preventing the birth defect and improving the memory |
| 03/18/2009 | CN101385752A Medicine composition for preventing the birth defect and improving the memory |
| 03/18/2009 | CN101385751A Medicine composition for preventing the birth defect and improving the memory |
| 03/18/2009 | CN101385736A Use of penoniflorin in preparing medicine for preventing and treating depression and medicine composition thereof |
| 03/18/2009 | CN101385734A Use of ginsenoside in preparing food and medicine for preventing age associated memory impairment and Alzheimer's disease associated dysmnesia |
| 03/18/2009 | CN101385726A Use of alpha-lipoic acid in preparing medicine or food for improving senile memory |
| 03/18/2009 | CN101385725A Use of green tea polyphenol in preparing medicine or food for preventing and treating senile memory impairment |
| 03/18/2009 | CN101385722A Method of preventing, treating and diagnosing disorders of protein aggregation |
| 03/18/2009 | CN101385600A Chinese herbal medicine health-care silk quilt |
| 03/18/2009 | CN100469784C Use of glycosides of mono- and diacylglycerol as anti-inflammatory agents |
| 03/18/2009 | CN100469767C Bipiperidinyl-derivatives and their use as chemokine receptor inhibitors |
| 03/18/2009 | CN100469399C Electrothermal cap for dredging cerebral meridian and its making process |
| 03/18/2009 | CN100469386C Medicine composition for treating college entrance examination syndrome and its use |
| 03/18/2009 | CN100469382C Exterior-applied Chinese medicine for treating facial palsy |
| 03/18/2009 | CN100469381C Compound capsule for decreasing alcohol and protecting liver |
| 03/18/2009 | CN100469368C Use of adatanserin for treating neurogenerative disorders |
| 03/18/2009 | CN100469363C Therapeutic combinations of fatty acids |
| 03/18/2009 | CN100469361C Method and composition for treating or preventing catabolism or stimulating anabolism in a mammal undergoing metabolic stress |
| 03/17/2009 | US7504437 Acetylcholinesterase inhibitor; Alzheimer's diseases, Hubtington disease, antidepressants |
| 03/17/2009 | US7504421 Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and their use |
| 03/17/2009 | US7504412 Melanin concentrating hormone receptor antagonists; such as n-(2-cyclopropyl-3-methylimidazo[1,2-a]-pyridin-6-yl)-4-(2-pyridyl)benzamide; central nervous system, cardiovascular and metabolic disorders; synthesis |
| 03/17/2009 | US7504411 2,3,6-Trisubstituted-4-pyrimidone derivatives |
| 03/17/2009 | US7504407 2-substituted-4-(imidazolyl or pyrazolyl alkyl)amino-6-phenyl-pyrrolo[2,3-D]pyrimidines; Adenosine receptor inhibitors; asthma, bronchodilators, vision defects, antiischemic and antiinflammatory agents |
| 03/17/2009 | US7504404 Compounds as metabotropic glutamate receptor antagonists |
| 03/17/2009 | US7504398 potent and selective antagonists of adenosine receptors; Parkinson's disease, asthma, allergies, inflammation, atherosclerosis, hypertension, gastrointestinal disorders, cell proliferation and autoimmune diseases; sulfonamidation |
| 03/17/2009 | US7504395 Treatment for attention-deficit hyperactivity disorder |
| 03/17/2009 | US7504393 Benzylamine analogues |
| 03/17/2009 | US7504392 2,3,4,5-tetrahydro-1H-3-benzazepines and their medical use |
| 03/17/2009 | US7504390 Benzoxazepine derivatives and their use as AMPA receptor stimulators |
| 03/17/2009 | US7504257 Embryonic stem cells and neural progenitor cells derived therefrom |
| 03/17/2009 | US7504247 2-O sulfatase compositions and methods of degradation therewith |
| 03/17/2009 | US7504232 Identifying immunomodulators for diagnosis and treatment of inflammatory, granulomatous, fibrosis, multiple sclerosis, bacterial or viral diseases |
| 03/17/2009 | US7504100 Method for delivering a biological compound using neural progenitor cells derived from whole bone marrow |
| 03/17/2009 | US7504098 Method for introducing a biological molecule using a viral envelope and heparin and system therefore |
| 03/17/2009 | CA2502731C Sustained release composition for oral administration of drugs |
| 03/17/2009 | CA2412161C Thyroid receptor ligands, pharmaceutical compositions comprising them and their use in the treatment of disorders influenced by thyroid hormones |
| 03/17/2009 | CA2340405C Substituted 4-amino-2-aryl-pyrimidines, their production and use and pharmaceutical preparations containing same |
| 03/17/2009 | CA2328234C Compounds that inhibit the binding of integrins to their receptors |
| 03/17/2009 | CA2316351C Benzopyran and benzothiopyran derivatives having retinoid antagonist-like activity |
| 03/17/2009 | CA2192438C Novel composition stimulating the cerebral activity and based on alkaloids having an eburnamenine nucleus, and preparation methods |
| 03/12/2009 | WO2009033079A1 Externally masked neopentyl sulfonyl ester cyclization release prodrugs of acamprosate, compositions thereof, and methods of use |
| 03/12/2009 | WO2009033069A1 Simple pantoic acid ester neopentyl sulfonyl ester cyclization release prodrugs of acamprosate, compositions thereof, and methods of use |
| 03/12/2009 | WO2009033061A1 Masked carboxylate neopentyl sulfonyl ester cyclization release prodrugs of acamprosate, compositions thereof, and methods of use |
| 03/12/2009 | WO2009033054A1 Complex pantoic acid ester neopentyl sulfonyl ester cyclization release prodrugs of acamprosate, compositions thereof, and methods of use |
| 03/12/2009 | WO2009032600A1 7-keto dhea for psychiatric use |
| 03/12/2009 | WO2009032246A2 Particulate compositions for delivery of poorly soluble drugs |
| 03/12/2009 | WO2009031919A1 Alcoholism recurrence preventing agent and method for the use thereof |
| 03/12/2009 | WO2009031705A1 PHARMACEUTICAL COMPOSITION FOR INHIBITING ACCUMULATION OF AMYLOID-β PROTEIN |
| 03/12/2009 | WO2009031029A1 Treatment of cns and pain disorders |
| 03/12/2009 | WO2009030996A1 Triazole compounds as toll-like receptor (tlr) agonists |
| 03/12/2009 | WO2009030746A1 Novel phenylurea derivatives, inhibitors of the enzyme soat-1, and pharmaceutical and cosmetic compositions containing them |
| 03/12/2009 | WO2009030716A1 Piperazine derivative having affinity for the histamine h3 receptor |
| 03/12/2009 | WO2009030499A1 Use of glp-1 analogues for the treatment of disorders associated with dysfunctional synaptic transmission |
| 03/12/2009 | WO2009030498A2 Use of gip for the treatment of disorders associated with dysfunctional synaptic transmission |
| 03/12/2009 | WO2009030270A1 Dihydroindole derivatives useful in parkinson's disease |
| 03/12/2009 | WO2009030257A1 Methods and compounds for treating diseases caused by reactive oxygen species |
| 03/12/2009 | WO2009030065A1 INTERFERON ALPHA 2a MODIFIED BY POLYETHYLENE GLYCOL, ITS SYNTHESIS PROCESS AND APPLICATION |
| 03/12/2009 | WO2009004082A3 Anticonvulsive pharmaceutical compositions |
| 03/12/2009 | WO2009001043A3 Duloxetine formulation |
| 03/12/2009 | WO2008155668A3 Heteroarylamide pyrimidone compounds |
| 03/12/2009 | WO2008149244A3 Compositions and methods comprising analogues of radicicol a |
| 03/12/2009 | WO2008139235A3 Novel piperazine salts as d3/d2 antagonists |
| 03/12/2009 | WO2008116185A3 Substituted pyrimidines as adenosine receptor antagonists |
| 03/12/2009 | WO2008014219A8 Thiozolidinedione derivatives as p13 kinase inhibitors |
| 03/12/2009 | US20090069445 Propofol-containing fat emulsions |
| 03/12/2009 | US20090069444 Method to Ameliorate Oxidative Stress and Improve Working Memory Via Pterostilbene Administration |
| 03/12/2009 | US20090069443 Sedative Effect-Imparting Agent And Sedative Perfume Composition Containing The Same |
| 03/12/2009 | US20090069440 Deuterium-enriched atomoxetine |
| 03/12/2009 | US20090069434 Cystalline form VI of agomelatine, a process for its preparation and pharmaceutical compositions containing it |
| 03/12/2009 | US20090069432 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease |
| 03/12/2009 | US20090069431 Deuterium-enriched milnacipran |
| 03/12/2009 | US20090069430 Dibenzene derivatives as calcium channel blockers |
| 03/12/2009 | US20090069428 Catalytic antioxidants and methods of use |
| 03/12/2009 | US20090069423 Germinating sunflower seeds in sucrose and oxygen controlled environment to enhance production of eicosapentaenoyl-L-carnitine, docosahexaenyl-L-carnitine; treatment of Alzheimer's, geriatric depression and schizophrenia |
| 03/12/2009 | US20090069419 Masked carboxylate neopentyl sulfonyl ester cyclization release prodrugs of acamprosate, compositions thereof, and methods of use |
| 03/12/2009 | US20090069418 Compositions and Methods for the Treatment of Disorders Associated with Aberrant Vasodilation |
| 03/12/2009 | US20090069405 Treatment of cns and pain disorders |
| 03/12/2009 | US20090069399 Deuterium-enriched frovatriptan |
| 03/12/2009 | US20090069391 such as N-hydroxy-6-{1-[(4-methoxybenzyl)amino]-2-[(4-methoxyphenyl)amino]-2-oxoethyl}-1-benzothiophene-2-carboxamide, used to treat cancer, tumors, neurodegenerative, autoimmune, allergic and inflammatory diseases, and as histone deacetylase inhibitors |
| 03/12/2009 | US20090069390 Lennox-Gastaut syndrome and/or seizure disorders |
| 03/12/2009 | US20090069382 Bicyclic Angiotensin II Agonists |
| 03/12/2009 | US20090069378 Deuterium-enriched donepezil |
| 03/12/2009 | US20090069373 Quinoline Acids |
| 03/12/2009 | US20090069370 Azacyclylisoquinolinone and isoindolinone derivatives as histamine-3 antagonists |
| 03/12/2009 | US20090069362 Novel Spiro-benzo[c]chromene derivatives useful as modulators of the estrogen receptors |
| 03/12/2009 | US20090069355 Bicyclic pyrazolone cytokine inhibitors |
| 03/12/2009 | US20090069348 Use of Inhibitors of the Renin-Angiotensin System |